HCV diagnostics have recently been added to the WHO Model List of Essential In Vitro Diagnostics. Improving access to rapid, simple, and affordable HCV diagnostics is critical to achieve global HCV elimination
This recent commentary "Hepatitis C Virus Diagnosis and the Holy Grail" discusses the complex challenges to improve access to existing tests, and the ongoing search for the development of the "holy grail" point-of-care test for active HCV infection.
The article is open access, thanks to the support of MSF ACCESS and CHAI, and can be found at: https://www.sciencedirect.com/science/article/pii/S0891552018300205?via%3Dihub
Full citation: Applegate TL, Fajardo E, Sacks JA. Hepatitis C Virus Diagnosis and the Holy Grail. Infect Dis Clin North Am. 32 (2): 425-445, June 2018, doi: 10.1016/j.idc.2018.02.010